Molecular genetics of long QT syndrome

Molecular Genetics and Metabolism

Volumn 101, Issue 1, 2010, Pages 1-8

  Bokil, Nilesh J ^a   Baisden, John M ^a   Radford, Dorothy J ^b   Summers, Kim M ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Brugada syndrome; Cardiac ion channels; Epigenetic modification; Jervell and Lange Neilson syndrome; KCNQ1 potassium channel; Long QT syndrome; Romano Ward syndrome

Indexed keywords

POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5;

AKAP9 GENE; ANK2 GENE; ATP1B1 GENE; CACNA1C GENE; CAV3 GENE; CNOT1 GENE; CNOT3 GENE; EPIGENETICS; GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; GINS3 GENE; HUMAN; KCHIP2 GENE; KCND2 GENE; KCND3 GENE; KCNH2 GENE; LITAF GENE; LONG QT SYNDROME; MOLECULAR GENETICS; NDRG4 GENE; NONHUMAN; NOS1AP GENE; PHENOTYPIC VARIATION; PLN GENE; PRIORITY JOURNAL; REVIEW; RNF207 GENE; SCN4B GENE; SETD6 GENE; SNTA1 GENE;

EID: 77955662261     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.05.011     Document Type: Review

References (87)

1. Smith W.M. Cardiac repolarisation: the long and short of it. Med. J. Aust. 2008, 188:688-689.
2. Schwartz P.J., Periti M., Malliani A. The Long Q-T syndrome. Am. Heart J. 1975, 89:378-390.
3. Roden D.M. Clinical practice. Long-QT syndrome. Engl. J. Med. 2008, 358:169-176.
4. Ward O.C. A new familial cardiac syndrome in children. J. Ir Med. Assoc. 1964, 54:103-106.
5. Romano C. Congenital cardiac arrhythmia. Lancet 1965, 1:658-659.
6. Jervell A., Lange-Nielsen F. Congenital deaf-mutism. Functional heart disease with prolongation of the Q-T interval and sudden death. Am. Heart J. 1957, 54:59-68.
7. Montanez A., Ruskin J.N., Hebert P.R., Lamas G.A., Hennekens C.H. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch. Intern. Med. 2004, 164:943-948.
8. Schwartz P.J. The congenital Long QT syndromes from genotype to phenotype: clinical implications. J. Intern. Med. 2006, 259:39-47.
9. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the Long QT syndrome. An update Circulation 1993, 88:782-784.
10. Moss A.J., Schwartz P.J., Crampton R.S., Locati E., Carleen E. The long QT syndrome: a prospective international study. Circulation 1985, 71:17-21.
11. Hashiba K. Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome. Ann. NY Acad. Sci. 1992, 644:142-156.
12. Rivero A., Curtis A.B. Sex differences in arrhythmias. Curr. Opin. Cardiol. 2010, 25:8-15.
13. Hofman N., Wilde A.A., Kaab S., van Langen I.M., Tanck M.W., Mannens M.M., Hinterseer M., Beckmann B.M., Tan H.L. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?. Eur. Heart J. 2007, 28:575-580.
14. Moss A.J., Zareba W., Benhorin J., Locati E.H., Hall W.J., Robinson J.L., Schwartz P.J., Towbin J.A., Vincent G.M., Lehmann M.H. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995, 92:2929-2934.
15. Zhang L., Timothy K.W., Vincent G.M., Lehmann M.H., Fox J., Giuli L.C., Shen J., Splawski I., Priori S.G., Compton S.J., Yanowitz F., Benhorin J., Moss A.J., Schwartz P.J., Robinson J.L., Wang Q., Zareba W., Keating M.T., Towbin J.A., Napolitano C., Medina A. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000, 102:2849-2855.
16. Takenaka K., Ai T., Shimizu W., Kobori A., Ninomiya T., Otani H., Kubota T., Takaki H., Kamakura S., Horie M. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003, 107:838-844.
17. Wong J.A., Gula L.J., Klein G.J., Yee R., Skanes A.C., Krahn A.D. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ. Arrhythm. Electrophysiol. 2010, 3:120-125.
18. Goldenberg I., Moss A.J. Long QT syndrome. J. Am. Coll. Cardiol. 2008, 51:2291-2300.
19. Vohra J. The Long QT Syndrome. Heart Lung Circ 2007, 16(Suppl. 3):S5-12.
20. Shimizu W., Aiba T., Antzelevitch C. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr Pharm Des 2005, 11:1561-1572.
21. Skinner J.R. Guidelines for the diagnosis and management of familial Long QT syndrome. Heart Lung. Circ. 2007, 16:22-24.
22. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., Cappelletti D. Risk stratification in the long-QT syndrome. N Engl. J. Med. 2003, 348:1866-1874.
23. Liu J.F., Moss A.J., Jons C., Benhorin J., Schwartz P.J., Spazzolini C., Crotti L., Ackerman M.J., McNitt S., Robinson J.L., Qi M., Goldenberg I., Zareba W. Mutation-specific risk in two genetic forms of type 3 Long QT syndrome. Am. J. Cardiol. 2010, 105:210-213.
24. Benhorin J., Taub R., Goldmit M., Kerem B., Kass R.S., Windman I., Medina A. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?. Circulation 2000, 101:1698-1706.
25. Priori S.G., Napolitano C., Schwartz P.J., Bloise R., Crotti L., Ronchetti E. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2000, 102:945-947.
26. Meyer J.S., Mehdirad A., Salem B.I., Kulikowska A., Kulikowski P. Sudden arrhythmia death syndrome: importance of the Long QT syndrome. Am. Fam. Physician 2003, 68:483-488.
27. Bai R., Napolitano C., Bloise R., Monteforte N., Priori S.G. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ. Arrhythm. Electrophysiol. 2009, 2:6-15.
28. Hofman N., Wilde A.A., Tan H.L. Diagnostic criteria for congenital Long QT syndrome in the era of molecular genetics: do we need a scoring system?. Eur. Heart J. 2007, 28:1399.
29. Tester D.J., Ackerman M.J. Genetic testing for cardiac channelopathies: ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm 2005, 2:675-677.
30. Tester D.J., Will M.L., Ackerman M.J. Mutation detection in congenital Long QT syndrome: cardiac channel gene screen using PCR DHPLC, and direct DNA sequencing. Methods Mol Med 2006, 128:181-207.
31. Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E., Nastoli J., Bottelli G., Cerrone M., Leonardi S. Genetic testing in the Long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005, 294:2975-2980.
32. Van Langen I.M., Birnie E., Alders M., Jongbloed R.J., Wilde A.A. The use of genotype-phenotype correlations in mutation analysis for the Long QT syndrome. J. Med. Genet. 2003, 40:141-145.
33. MacRae C.A. Closer look at genetic testing in long-QT syndrome: will DNA diagnostics ever be enough?. Circulation 2009, 120:1745-1748.
34. Yang T., Chung S.K., Zhang W., Mullins J.G., McCulley C.H., Crawford J., MacCormick J., Eddy C.A., Shelling A.N., French J.K., Yang P., Skinner J.R., Roden D.M., Rees M.I. Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome. Circ. Arrhythm. Electrophysiol. 2009, 2:417-426.
35. Zhang L., Vincent G.M., Baralle M., Baralle F.E., Anson B.D., Benson D.W., Whiting B., Timothy K.W., Carlquist J., January C.T., Keating M.T., Splawski I. An intronic mutation causes Long QT syndrome. J. Am. Coll. Cardiol. 2004, 44:1283-1291.
36. Schwartz P.J., Priori S.G., Napolitano C. How really rare are rare diseases? the intriguing case of independent compound mutations in the Long QT syndrome. J. Cardiovasc. Electrophysiol. 2003, 14:1120-1121.
37. Summers K.M., Bokil N.J., Lu F.T., Low J.T., Baisden J.M., Duffy D., Radford D.J. Mutations at KCNQ1 and an unknown locus cause Long QT syndrome in a large Australian family: implications for genetic testing. Am. J. Med. Genet. A 2010, 152A:613-621.
38. Westenskow P., Splawski I., Timothy K.W., Sanguinetti M.C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004, 109:1834-1841.
39. Abriel H. Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J. Mol. Cell Cardiol. 2010, 48:2-11.
40. Patel U., Pavri B.B. Short QT syndrome: a review. Cardiol. Rev. 2009, 17:300-303.
41. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., Wang X. International union of pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 2005, 57:473-508.
42. Catterall W.A., Goldin A.L., Waxman S.G. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57:397-409.
43. Catterall W.A., Perez-Reyes E., Snutch T.P., Striessnig J. International union of pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 2005, 57:411-425.
44. Charpentier F., Merot J., Loussouarn G., Baro I. Delayed rectifier K(+) currents and cardiac repolarization. J. Mol. Cell Cardiol. 2010, 48:37-44.
45. Harmer S.C., Wilson A.J., Aldridge R., Tinker A. Mechanisms of disease pathogenesis in Long QT syndrome type 5. Am. J. Physiol. Cell Physiol. 2010, 298:C263-273.
46. Roden D.M. Taking the "idio" out "idiosyncratic": predicting torsades de pointes. Pacing Clin. Electrophysiol. 1998, 21:1029-1034.
47. Isbrandt D., Leicher T., Waldschutz R., Zhu X., Luhmann U., Michel U., Sauter K., Pongs O. Gene structures and expression profiles of three human KCND (Kv4) potassium channels mediating A-type currents I(TO) and I(SA). Genomics 2000, 64:144-154.
48. Postma A.V., Bezzina C.R., de Vries J.F., Wilde A.A., Moorman A.F., Mannens M.M. Genomic organisation and chromosomal localisation of two members of the KCND ion channel family, KCND2 and KCND3. Hum. Genet. 2000, 106:614-619.
49. Salama G., London B. Mouse models of Long QT syndrome. J. Physiol. 2007, 578:43-53.
50. Guo W., Jung W.E., Marionneau C., Aimond F., Xu H., Yamada K.A., Schwarz T.L., Demolombe S., Nerbonne J.M. Targeted deletion of Kv4.2 eliminates I(to, f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ. Res. 2005, 97:1342-1350.
51. Kuo H.C., Cheng C.F., Clark R.B., Lin J.J., Lin J.L., Hoshijima M., Nguyen-Tran V.T., Gu Y., Ikeda Y., Chu P.H., Ross J., Giles W.R., Chien K.R. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001, 107:801-813.
52. Seebohm G., Strutz-Seebohm N., Ureche O.N., Henrion U., Baltaev R., Mack A.F., Korniychuk G., Steinke K., Tapken D., Pfeufer A., Kaab S., Bucci C., Attali B., Merot J., Tavare J.M., Hoppe U.C., Sanguinetti M.C., Lang F. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels. Circ. Res. 2008, 103:1451-1457.
53. Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J., Kass R.S. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc. Natl. Acad. Sci. USA 2007, 104:20990-20995.
54. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., Kass R.S. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
55. Walker V.E., Wong M.J., Atanasiu R., Hantouche C., Young J.C., Shrier A. Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem 2010, 285:3319-3326.
56. Gavillet B., Rougier J.S., Domenighetti A.A., Behar R., Boixel C., Ruchat P., Lehr H.A., Pedrazzini T., Abriel H. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ. Res. 2006, 99:407-414.
57. Ueda K., Valdivia C., Medeiros-Domingo A., Tester D.J., Vatta M., Farrugia G., Ackerman M.J., Makielski J.C. Syntrophin mutation associated with Long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc. Natl. Acad. Sci. USA 2008, 105:9355-9360.
58. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., Song L.S., Haurogne K., Kyndt F., Ali M.E., Rogers T.B., Lederer W.J., Escande D., Le Marec H., Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421:634-639.
59. Hashemi S.M., Hund T.J., Mohler P.J. Cardiac ankyrins in health and disease. J. Mol. Cell Cardiol. 2009, 47:203-209.
60. Vatta M., Ackerman M.J., Ye B., Makielski J.C., Ughanze E.E., Taylor E.W., Tester D.J., Balijepalli R.C., Foell J.D., Li Z., Kamp T.J., Towbin J.A. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006, 114:2104-2112.
61. Cronk L.B., Ye B., Kaku T., Tester D.J., Vatta M., Makielski J.C., Ackerman M.J. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 2007, 4:161-166.
62. Newton-Cheh C., Eijgelsheim M., Rice K.M., de Bakker P.I., Yin X., Estrada K., Bis J.C., Marciante K., Rivadeneira F., Noseworthy P.A., Sotoodehnia N., Smith N.L., Rotter J.I., Kors J.A., Witteman J.C., Hofman A., Heckbert S.R., O'Donnell C.J., Uitterlinden A.G., Psaty B.M., Lumley T., Larson M.G., Stricker B.H. Common variants at ten loci influence QT interval duration in the QTGEN study. Nat. Genet. 2009, 41:399-406.
63. Pfeufer A., Sanna S., Arking D.E., Muller M., Gateva V., Fuchsberger C., Ehret G.B., Orru M., Pattaro C., Kottgen A., Perz S., Usala G., Barbalic M., Li M., Putz B., Scuteri A., Prineas R.J., Sinner M.F., Gieger C., Najjar S.S., Kao W.H., Muhleisen T.W., Dei M., Happle C., Mohlenkamp S., Crisponi L., Erbel R., Jockel K.H., Naitza S., Steinbeck G., Marroni F., Hicks A.A., Lakatta E., Muller-Myhsok B., Pramstaller P.P., Wichmann H.E., Schlessinger D., Boerwinkle E., Meitinger T., Uda M., Coresh J., Kaab S., Abecasis G.R., Chakravarti A. Common variants at ten loci modulate the QT interval duration in the QTSCD study. Nat. Genet. 2009, 41:407-414.
64. Shah S.H., Pitt G.S. Genetics of cardiac repolarization. Nat Genet 2009, 41:388-389.
65. Neely G.G., Kuba K., Cammarato A., Isobe K., Amann S., Zhang L., Murata M., Elmen L., Gupta V., Arora S., Sarangi R., Dan D., Fujisawa S., Usami T., Xia C.P., Keene A.C., Alayari N.N., Yamakawa H., Elling U., Berger C., Novatchkova M., Koglgruber R., Fukuda K., Nishina H., Isobe M., Pospisilik J.A., Imai Y., Pfeufer A., Hicks A.A., Pramstaller P.P., Subramaniam S., Kimura A., Ocorr K., Bodmer R., Penninger J.M. A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 2010, 141:142-153.
66. Mancini-Dinardo D., Steele S.J., Levorse J.M., Ingram R.S., Tilghman S.M. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev. 2006, 20:1268-1282.
67. Smilinich N.J., Day C.D., Fitzpatrick G.V., Caldwell G.M., Lossie A.C., Cooper P.R., Smallwood A.C., Joyce J.A., Schofield P.N., Reik W., Nicholls R.D., Weksberg R., Driscoll D.J., Maher E.R., Shows T.B., Higgins M.J. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc. Natl. Acad. Sci. USA 1999, 96:8064-8069.
68. Mancini-DiNardo D., Steele S.J., Ingram R.S., Tilghman S.M. A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. Hum. Mol. Genet. 2003, 12:283-294.
69. Higashimoto K., Soejima H., Saito T., Okumura K., Mukai T. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. Cytogenet. Genome Res. 2006, 113:306-312.
70. Gould T.D., Pfeifer K. Imprinting of mouse Kvlqt1 is developmentally regulated. Hum. Mol. Genet. 1998, 7:483-487.
71. Lee M.P., Hu R.J., Johnson L.A., Feinberg A.P. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet. 1997, 15:181-185.
72. Kim K.P., Thurston A., Mummery C., Ward-van Oostwaard D., Priddle H., Allegrucci C., Denning C., Young L. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 2007, 17:1731-1742.
73. Jongbloed R.J., Wilde A.A., Geelen J.L., Doevendans P., Schaap C., Van Langen I., van Tintelen J.P., Cobben J.M., Beaufort-Krol G.C., Geraedts J.P., Smeets H.J. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum. Mutat. 1999, 13:301-310.
74. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., VanRaay T.J., Shen J., Timothy K.W., Vincent G.M., de Jager T., Schwartz P.J., Toubin J.A., Moss A.J., Atkinson D.L., Landes G.M., Connors T.D., Keating M.T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 1996, 12:17-23.
75. Imboden M., Swan H., Denjoy I., Van Langen I.M., Latinen-Forsblom P.J., Napolitano C., Fressart V., Breithardt G., Berthet M., Priori S., Hainque B., Wilde A.A., Schulze-Bahr E., Feingold J., Guicheney P. Female predominance and transmission distortion in the long-QT syndrome. N Engl. J. Med. 2006, 355:2744-2751.
76. Nishio Y., Makiyama T., Itoh H., Sakaguchi T., Ohno S., Gong Y.Z., Yamamoto S., Ozawa T., Ding W.G., Toyoda F., Kawamura M., Akao M., Matsuura H., Kimura T., Kita T., Horie M. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in Long QT syndrome. J. Am. Coll. Cardiol. 2009, 54:812-819.
77. Paulussen A.D., Gilissen R.A., Armstrong M., Doevendans P.A., Verhasselt P., Smeets H.J., Schulze-Bahr E., Haverkamp W., Breithardt G., Cohen N., Aerssens J. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced Long QT syndrome patients. J. Mol. Med. 2004, 82:182-188.
78. Tester D.J., Will M.L., Haglund C.M., Ackerman M.J. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for Long QT syndrome genetic testing. Heart Rhythm 2005, 2:507-517.
79. Wainscoat J.S., Kanavakis E., Wood W.G., Letsky E.A., Huehns E.R., Marsh G.W., Higgs D.R., Clegg J.B., Weatherall D.J. Thalassaemia intermedia in Cyprus: the interaction of alpha and beta thalassaemia. Br. J. Haematol. 1983, 53:411-416.
80. J. Brisbane, J. Goldblatt, T. Edkins, I. Walpole, L. D'Osrogna, ACCE Review Summary: The Long-QT Syndrome (LQTS), Office of Population Health Genomics, Department of Health, Government of Western Australia, Perth, 2009. Available from: .
81. van Langen I.M., Hofman N., Tan H.L., Wilde A.A. Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann. Med. 2004, 36(Suppl. 1):116-124.
82. Moss A.J., Schwartz P.J. 25th anniversary of the international long-QT syndrome registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation 2005, 111:1199-1201.
83. Lehnart S.E., Ackerman M.J., Benson D.W., Brugada R., Clancy C.E., Donahue J.K., George A.L., Grant A.O., Groft S.C., January C.T., Lathrop D.A., Lederer W.J., Makielski J.C., Mohler P.J., Moss A., Nerbonne J.M., Olson T.M., Przywara D.A., Towbin J.A., Wang L.H., Marks A.R. Inherited arrhythmias: a national heart, lung, and blood institute and office of rare diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007, 116:2325-2345.
84. Vincent G.M. Romano-Ward syndrome, Gene Reviews 2009, The University of Washington, Seattle.
85. Mohler P.J., Splawski I., Napolitano C., Bottelli G., Sharpe L., Timothy K., Priori S.G., Keating M.T., Bennett V. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc. Natl. Acad. Sci. USA 2004, 101:9137-9142.
86. Jentsch T.J., Hubner C.A., Fuhrmann J.C. Ion channels: function unravelled by dysfunction. Nat. Cell Biol. 2004, 6:1039-1047.
87. Moss A.J., Shimizu W., Wilde A.A., Towbin J.A., Zareba W., Robinson J.L., Qi M., Vincent G.M., Ackerman M.J., Kaufman E.S., Hofman N., Seth R., Kamakura S., Miyamoto Y., Goldenberg I., Andrews M.L., McNitt S. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007, 115:2481-2489.